Danny Farin is the CEO of Perflow Medical, that develops and commercializes devices for hemorrhagic and ischemic stroke. Danny is a serial entrepreneur. Prior to Perflow, he co-founded and was CEO at Eon Surgical, which commercialize a platform for scarless laparoscopy procedures. Eon was acquired by Teleflex Medical back in 2013.
Here are some of the questions we asked Danny:
02:04 Tell us about your background and what you are up to these days.
06:52 Can you share what you think you did right in the Eon journey and how did that acquisition happen so quickly?
10:30 Can you elaborate on the differences between corporate thinking versus a startup thinking?
15:45 Can you share a bit about your experience with Rad Biomed incubator? And if you have any kind of takeaways about your journey with Eon and now Perflow, and the advantages of being part of a system like that?
19:10 How did Perflow come to be? And when you decided to join the team, what were the early warning sign or the signals for you to know that you have a good technology that has a potential to make a real dent or change in the market?
23:19 When you entered the neurosurgery market did you have a moment of panic and if there was that moment, what helped you calm down and fill in the gaps
30:00 You are involved in a digital health startup called CVAid that is intended or is targeting the problem of early detection of strokeCould you tell us a little bit about that?
37:00 We are curious to hear your experience and what you're imagining will happen going forward in that bundling of diagnostics and therapeutics.
39:45 In which territories is Perflow currently selling?
41:00 What kind of advice or tips would you have for companies who are looking to sell medical devices through distributors?
Danny Farin is the CEO of Perflow Medical, that develops and commercializes devices for hemorrhagic and ischemic stroke. Danny is a serial entrepreneur. Prior to Perflow, he co-founded and was CEO at Eon Surgical, which commercialize a platform for scarless laparoscopy procedures. Eon was acquired by Teleflex Medical back in 2013.
Here are some of the questions we asked Danny:
02:04 Tell us about your background and what you are up to these days.
06:52 Can you share what you think you did right in the Eon journey and how did that acquisition happen so quickly?
10:30 Can you elaborate on the differences between corporate thinking versus a startup thinking?
15:45 Can you share a bit about your experience with Rad Biomed incubator? And if you have any kind of takeaways about your journey with Eon and now Perflow, and the advantages of being part of a system like that?
19:10 How did Perflow come to be? And when you decided to join the team, what were the early warning sign or the signals for you to know that you have a good technology that has a potential to make a real dent or change in the market?
23:19 When you entered the neurosurgery market did you have a moment of panic and if there was that moment, what helped you calm down and fill in the gaps
30:00 You are involved in a digital health startup called CVAid that is intended or is targeting the problem of early detection of strokeCould you tell us a little bit about that?
37:00 We are curious to hear your experience and what you're imagining will happen going forward in that bundling of diagnostics and therapeutics.
39:45 In which territories is Perflow currently selling?
41:00 What kind of advice or tips would you have for companies who are looking to sell medical devices through distributors?